Request Demo
Last update 27 Apr 2025
Beijing Kexing Zhongwei Biotech Co. Ltd.
Last update 27 Apr 2025
Overview
Tags
Infectious Diseases
Other Diseases
Respiratory Diseases
Prophylactic vaccine
Conjugated vaccine
Inactivated vaccine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT06800261
A Randomized, Double-blind, Positive Controlled Phase Ib Clinical Trial to Evaluate the Safety and Immunogenicity of 24-valent Pneumococcal Conjugate Vaccine in Children Aged 2 (Minimum 42 Days)-23 Months
NCT06939777
A Randomized, Double-Blind, Controlled, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants
CTR20250157
评价口服六价重配轮状病毒减毒活疫苗（Vero细胞）在健康婴儿中免疫原性和安全性的随机、双盲、阳性对照Ⅱ期临床试验
[Translation] A randomized, double-blind, positive-controlled phase II clinical trial to evaluate the immunogenicity and safety of oral hexavalent reassortant rotavirus live attenuated vaccine (Vero cells) in healthy infants
100 Clinical Results associated with Beijing Kexing Zhongwei Biotech Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Beijing Kexing Zhongwei Biotech Co. Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Kexing Zhongwei Biotech Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 29 Apr 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
2
Preclinical
IND Application
5
3
IND Approval
Phase 1
5
4
Phase 2
Phase 3
3
2
NDA/BLA
Approved
1
2
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free